Xilio Therapeutics, Inc. (XLO)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
8. 88
-0.15
-1.6611%
$
59.37M Market Cap
- P/E Ratio
- Div Yield
55,700 Volume
-1.47 Eps
$ 9.03
Previous Close Want to track XLO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
XLO Earnings Reports FAQ
What is the earnings per share (EPS) for XLO?
The current EPS is -1.47.
What is the company's earnings growth rate?
Xilio Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Xilio Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Xilio Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for XLO at this time, as Xilio Therapeutics, Inc has no recent EPS data to calculate it.
